Myriad Genetics Highlights 2022 Research Findings that Help Advance More Accessible and Equitable Genetic Testing
07 févr. 2023 07h15 HE
|
Myriad Genetics, Inc.
SALT LAKE CITY, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, highlighted impactful clinical studies from 2022 that...
Global Genetic Testing Market Research Report 2023-2027: Pharmacogenomics Drives Further Growth
01 févr. 2023 07h23 HE
|
Research and Markets
Dublin, Feb. 01, 2023 (GLOBE NEWSWIRE) -- The "Genetic Testing Markets. Global Market Analysis with Forecasts by Applications, Technologies, Products and Users with Executive and Consultant Guides...
United States Hereditary Genetic Testing Market Report 2022: Analysis and Forecasts 2021-2032: Market is Expected to Grow by Over $20 Billion Over the Next Decade
09 janv. 2023 08h08 HE
|
Research and Markets
Dublin, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The "U.S. Hereditary Genetic Testing Market: Focus on Product, Sample Type, Application Area, and Genetic Testing Type - Analysis and Forecast, 2022-2032"...
Myriad Genetics Hires Five Senior Leaders to Advance Commercial Growth Plans
19 déc. 2022 16h05 HE
|
Myriad Genetics, Inc.
New leaders to elevate product portfolio, customer-centric commercial capabilities, and sales and marketing execution SALT LAKE CITY, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc.,...
Direct-To-Consumer (DTC) Genetic Testing Market Report 2022: Featuring 23 and Me, Gene by Gene, Quest Diagnostics & More
16 déc. 2022 08h03 HE
|
Research and Markets
Dublin, Dec. 16, 2022 (GLOBE NEWSWIRE) -- The "Direct-To-Consumer (DTC) Genetic Testing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive...
WellSpan Health and Helix announce partnership to improve patient health outcomes through new population genomics program
08 déc. 2022 08h50 HE
|
WellSpan Health
York, Pa., Dec. 08, 2022 (GLOBE NEWSWIRE) -- WellSpan Health and Helix, the nation’s leading population genomics and viral surveillance company, announced today a partnership to create a...
Rare Disease Genetic Testing Market Report 2022: Increased Number of Patients Undergoing Testing Presents Opportunities
30 nov. 2022 04h03 HE
|
Research and Markets
Dublin, Nov. 30, 2022 (GLOBE NEWSWIRE) -- The "Rare Disease Genetic Testing Market Share, Size, Trends, Industry Analysis Report, By Specialty; By Technology; By Disease Type; By End-Use; By Region;...
Global Epigenetics (Reagents, Enzymes, Instruments, Kits) Market Research Report 2022: A $14.79 Billion Market in 2026 - Long-term Forecasts to 2031
22 nov. 2022 06h05 HE
|
Research and Markets
Dublin, Nov. 22, 2022 (GLOBE NEWSWIRE) -- The "Epigenetics Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global epigenetics market is expected to grow...
Myriad Genetics Focuses on Expanding Access, Collaboration and Equity in Genetic Testing at National Society of Genetic Counselors Meeting
14 nov. 2022 08h00 HE
|
Myriad Genetics, Inc.
SALT LAKE CITY, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will spotlight efforts to expand access to prenatal and...
Global Pharmacogenomics Markets, Analysis & Forecasts, 2016-2021, 2021-2026F, 2031F: Focus on Next Generation Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarray
11 nov. 2022 06h28 HE
|
Research and Markets
Dublin, Nov. 11, 2022 (GLOBE NEWSWIRE) -- The "Pharmacogenomics Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global pharmacogenomics market is expected...